Mylan N.V. (NASDAQ:MYL) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Tuesday.

Several other analysts also recently weighed in on MYL. Cowen and Company restated a “hold” rating and set a $30.00 target price (down from $43.00) on shares of Mylan N.V. in a research note on Wednesday, August 9th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $32.00 price target (down previously from $33.00) on shares of Mylan N.V. in a research note on Thursday, August 10th. Citigroup Inc. upgraded Mylan N.V. from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $36.00 to $42.00 in a research note on Wednesday, August 16th. Cantor Fitzgerald set a $34.00 price target on Mylan N.V. and gave the stock a “hold” rating in a research note on Wednesday, August 9th. Finally, Wells Fargo & Company set a $30.00 price target on Mylan N.V. and gave the company a “hold” rating in a report on Wednesday, August 9th. One analyst has rated the stock with a sell rating, nine have given a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $42.46.

Shares of Mylan N.V. (MYL) traded up 0.43% during midday trading on Tuesday, hitting $32.53. The stock had a trading volume of 4,166,479 shares. Mylan N.V. has a one year low of $29.39 and a one year high of $45.87. The company has a market cap of $17.45 billion, a P/E ratio of 26.30 and a beta of 1.30. The stock has a 50 day moving average of $31.43 and a 200-day moving average of $36.46.

Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by ($0.08). Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same period last year, the firm earned $1.16 EPS. The business’s quarterly revenue was up 15.7% on a year-over-year basis. Analysts forecast that Mylan N.V. will post $4.52 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/03/bidaskclub-upgrades-mylan-n-v-myl-to-hold.html.

A number of hedge funds and other institutional investors have recently modified their holdings of MYL. Global X Management Co. LLC boosted its stake in Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock valued at $118,000 after acquiring an additional 1,441 shares during the period. TLP Group LLC acquired a new stake in shares of Mylan N.V. during the 1st quarter worth approximately $200,000. Doliver Capital Advisors LP acquired a new stake in shares of Mylan N.V. during the 2nd quarter worth approximately $201,000. Eagle Global Advisors LLC acquired a new stake in shares of Mylan N.V. during the 2nd quarter worth approximately $205,000. Finally, Sheaff Brock Investment Advisors LLC acquired a new stake in shares of Mylan N.V. during the 2nd quarter worth approximately $210,000. 71.97% of the stock is currently owned by hedge funds and other institutional investors.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Analyst Recommendations for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.